pe
pep-05385 v1 CC-BY-SA-4.0

Denclatoxin-B anticancer peptide

A peptide studied in the lab for its potential to fight cancer cells; experimental, not yet an approved drug.

statuscomputed targetANTICANCER length46 aa refs1
anticancer
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 2 / 5 · 2 contributors
prediction metrics boltz-2 2.2.1
ipTM0.000
pTM0.455
avg pLDDT60.9
ranking score0.578
STRUCTURE · PEP-05385 × ANTICANCER
ranking0.578
?
RECEPTOR UNKNOWN
peptide conformation only · no target structure
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
sequence46 aa
15101520253035404546
KSCCRNTTARNCYNVC RIPGTPRPVCAATCDC KIITGTKCPPGYEK
in the news 27 articles
details expand to inspect
full evidence table1 metrics
metricvaluetool
ranking score 0.5782672166824341 boltz-2
3-letter notation
Lys-Ser-Cys-Cys-Arg-Asn-Thr-Thr-Ala-Arg-Asn-Cys-Tyr-Asn-Val-Cys-Arg-Ile-Pro-Gly-Thr-Pro-Arg-Pro-Val-Cys-Ala-Ala-Thr-Cys-Asp-Cys-Lys-Ile-Ile-Thr-Gly-Thr-Lys-Cys-Pro-Pro-Gly-Tyr-Glu-Lys
recipeboltz-2 2.2.1
parametervalue
modelboltz-2 2.2.1
weights
hardwarevast_v100_32gb
mlx version
python
random seed1
msa strategynone_monomer
runtime
predicted by
predicted at2026-05-23
citationbibtex
peptidemodel (2026). Denclatoxin-B anticancer peptide (pep-05385, v1). PeptideModel. https://peptidemodel.com/card/pep-05385
@peptide{pep05385,
  sequence = {KSCCRNTTARNCYNVCRIPGTPRPVCAATCDCKIITGTKCPPGYEK},
  target   = {anticancer},
  author   = {peptidemodel},
  year     = {2026},
  status   = {computed}
}
references 1 papers
[1] source scaffold
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use